These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
104 related items for PubMed ID: 1707216
1. [Response to chemotherapy in endocrine therapy-relapsed and -resistant prostate cancer]. Akimoto S, Akakura K, Masai M, Shimazaki J. Hinyokika Kiyo; 1991 Jan; 37(1):31-7. PubMed ID: 1707216 [Abstract] [Full Text] [Related]
2. [Chemotherapy of prostatic cancer]. Hirao Y, Kubota K, Yoshie T, Tabata S, Samma S, Ozono S, Okajima E, Sasaki K, Yoshikawa M, Tsumatani K. Hinyokika Kiyo; 1991 Aug; 37(8):817-24. PubMed ID: 1720273 [Abstract] [Full Text] [Related]
7. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II) and adriamycin in urothelial cancer]. Konami T, Wakabayashi Y, Kim T, Ishida A, Arai Y, Konishi T, Pak K, Takeuchi H, Tomoyoshi T, Watanabe J. Hinyokika Kiyo; 1989 Feb; 35(2):231-7. PubMed ID: 2472048 [Abstract] [Full Text] [Related]
8. [Chemo-endocrine therapy for newly diagnosed stage D2 prostate cancer]. Saito T, Kitamura Y, Komatsubara S. Hinyokika Kiyo; 2005 Dec; 51(12):789-92. PubMed ID: 16440724 [Abstract] [Full Text] [Related]
9. Chemotherapy for endocrine-therapy-refractory prostate cancer. Akimoto S, Ohki T, Akakura K, Masai M, Shimazaki J. Cancer Chemother Pharmacol; 1994 Dec; 35 Suppl():S18-22. PubMed ID: 7527733 [Abstract] [Full Text] [Related]
10. [Alternating combination chemotherapy (VIP-DMF) in patients with advanced adenocarcinoma of the prostate]. Yoshimoto J, Ochi J, Tanahashi T, Nanba K, Saegusa M, Hara M, Akagi T, Obama T, Tsushima T, Ozaki Y. Gan To Kagaku Ryoho; 1987 Feb; 14(2):434-9. PubMed ID: 2434029 [Abstract] [Full Text] [Related]
11. [Induction therapy with CDDP and ADM for stage D prostatic cancer and its clinical response]. Yushita Y, Sakai H, Nomata K, Suzu H, Minami Y, Ogawa S, Yamashita S, Kanetake H, Saito Y. Hinyokika Kiyo; 1990 Dec; 36(12):1415-21. PubMed ID: 2075879 [Abstract] [Full Text] [Related]
12. [Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group]. Uchida K, Takeshima H, Kikuchi K, Shimazui T, Miyanaga N, Kawai K, Akaza H, Tsuchiya A, Noguchi R, Hattori K, Manabe F, Matsuki K, Suzuki R, Ishikawa S, Kondo F, Kobayashi T, Koiso K. Gan To Kagaku Ryoho; 1998 Jul; 25(8):1179-87. PubMed ID: 9679581 [Abstract] [Full Text] [Related]
15. [Combination chemotherapy of cisplatin, vincristine and peplomycin for patients with head and neck carcinoma]. Tsukuda M, Tamamushi N, Mochimatsu I, Nakagawa C, Furukawa M, Kubota A, Hiiragi K, Nishimoto Y, Mitarai K, Oishi K. Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):486-90. PubMed ID: 2420278 [Abstract] [Full Text] [Related]
17. [Combination chemotherapy of diffuse large-cell non-Hodgkin's lymphoma--superiority of the adriamycin combination]. Tada A, Ohnoshi T, Hayashi K, Ueoka H, Ueno K, Murashima M, Mizuta J, Yoshida M, Kimura I. Gan To Kagaku Ryoho; 1987 Sep; 14(9):2692-6. PubMed ID: 2443077 [Abstract] [Full Text] [Related]
18. [Treatment of hormonal refractory adenocarcinoma of the prostate with ifosfamide (IFM) and the combination of vincristine ifosfamide and peplomycin (VIP)]. Nukui M, Nakao M, Nakagawa S, Toyoda K, Takada H, Ebisui K, Watanabe H, Miyakoda K, Kobayashi T, Fujiwara M. Hinyokika Kiyo; 1989 Mar; 35(3):415-20. PubMed ID: 2472052 [Abstract] [Full Text] [Related]